comparison of the effects of escitalopram and fluoxetine on cognitive condition in the stroke patients
Phase 4
- Conditions
- ischemic stroke.
- Registration Number
- IRCT20211114053059N1
- Lead Sponsor
- Oroumia University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Pending
- Sex
- All
- Target Recruitment
- 60
Inclusion Criteria
confirmed ischemic stroke
consent on enrollment
Exclusion Criteria
major depression patients
having no history of the aforementioned drug
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Dementia Rating Scale. Timepoint: 5th and 90th day after diagnosis. Method of measurement: questionnaire.
- Secondary Outcome Measures
Name Time Method